U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07095205) titled 'PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.' on July 15.
Brief Summary: In the brain, certain nerve cells communicate using a chemical called acetylcholine. Acetylcholine is thought to be important for several functions including mood, memory and wakefulness. The purpose of this study is to explore the role of these nerve cells in depression. Also, we would like to understand how nicotine, the study drug, works in depression and how it affects these nerve cells. To do this, brain imaging will be used before and after this treatment.
Study Start Date: Oct. 03, 2024
Study Type: INTERVENTIONA...